GTS Securities’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Sell
11,929
-12,105
-50% -$1.31M 0.04% 361
2025
Q4
$2.68M Sell
24,034
-8,447
-26% -$864K 0.09% 168
2025
Q3
$2.72M Buy
32,481
+26,008
+402% +$2.03M 0.1% 159
2025
Q2
$510K Sell
6,473
-23,279
-78% -$1.88M 0.02% 652
2025
Q1
$3.17M Buy
29,752
+15,542
+109% +$1.65M 0.14% 108
2024
Q4
$1.31M Buy
+14,210
New +$1.6M 0.06% 249
2024
Q3
Sell
-48,959
Closed -$5.73M 4116
2024
Q2
$5.73M Buy
48,959
+15,260
+45% +$1.72M 0.01% 780
2024
Q1
$4.23M Sell
33,699
-7,572
-18% -$881K 0.01% 978
2023
Q4
$4.19M Buy
41,271
+19,535
+90% +$1.75M 0.01% 1128
2023
Q3
$1.92M Sell
21,736
-1,239
-5% -$122K ﹤0.01% 1538
2023
Q2
$2.3M Buy
+22,975
New +$2.29M 0.07% 244

Other funds holding CURE

GTS Securities's CURE Position: Q1 2026 in Review

GTS Securities reduced its Direxion Daily Healthcare Bull 3X ETF (CURE) stake by 50% in Q1 2026, selling an estimated $1.31M and leaving 11,929 shares worth $1.09M. The position accounts for 0.04% of the portfolio, ranked #361.

GTS Securities first reported a position in CURE in Q2 2023 and has held it in 11 quarters since. The position peaked at $5.73M in Q2 2024. 15 funds tracked by Wall St. Rank hold CURE as of Q1 2026.

  • GTS Securities held 11,929 shares of Direxion Daily Healthcare Bull 3X ETF worth $1.09M as of Q1 2026.
  • GTS Securities sold 12,105 Direxion Daily Healthcare Bull 3X ETF shares in Q1 2026, an estimated $1.31M.
  • Direxion Daily Healthcare Bull 3X ETF made up 0.04% of GTS Securities's portfolio in Q1 2026, its #361 holding.
  • GTS Securities first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q2 2023 and has held it in 11 quarters since.
  • GTS Securities's Direxion Daily Healthcare Bull 3X ETF position peaked at $5.73M in Q2 2024.
  • 15 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.